Cleo Diagnostics Management
Management criteria checks 3/4
Cleo Diagnostics' CEO is Richard Allman, appointed in Oct 2022, has a tenure of 2.08 years. total yearly compensation is A$212.31K, comprised of 90.7% salary and 9.3% bonuses, including company stock and options. directly owns 1.17% of the company’s shares, worth A$525.00K. The average tenure of the management team and the board of directors is 2.2 years and 2.1 years respectively.
Key information
Richard Allman
Chief executive officer
AU$212.3k
Total compensation
| CEO salary percentage | 90.7% |
| CEO tenure | 2.1yrs |
| CEO ownership | 1.2% |
| Management average tenure | 2.2yrs |
| Board average tenure | 2.1yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | AU$212k | AU$193k | -AU$4m |
| Mar 31 2024 | n/a | n/a | -AU$4m |
| Dec 31 2023 | n/a | n/a | -AU$4m |
| Sep 30 2023 | n/a | n/a | -AU$3m |
| Jun 30 2023 | AU$414k | AU$132k | -AU$2m |
Compensation vs Market: Richard's total compensation ($USD138.05K) is below average for companies of similar size in the Australian market ($USD298.55K).
Compensation vs Earnings: Richard's compensation has been consistent with company performance over the past year.
CEO
Richard Allman (64 yo)
2.1yrs
Tenure
AU$212,314
Compensation
Dr. Richard Allman, Ph D., serves as Chief Executive Officer and Executive Director at Cleo Diagnostics Ltd. since October 10, 2022.He served as Chief Scientific Officer at Genetic Technologies Limited si...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 2.1yrs | AU$212.31k | 1.17% A$ 525.0k | |
| Chief Scientific Officer & Executive Director | 2.2yrs | AU$191.07k | 0.39% A$ 175.0k | |
| Lead Medical Advisor & Independent Non-Executive Director | no data | AU$41.74k | 0.97% A$ 437.5k | |
| Company Secretary | 2.2yrs | no data | no data |
2.2yrs
Average Tenure
Experienced Management: COV's management team is considered experienced (2.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 2.1yrs | AU$212.31k | 1.17% A$ 525.0k | |
| Chief Scientific Officer & Executive Director | 2.2yrs | AU$191.07k | 0.39% A$ 175.0k | |
| Lead Medical Advisor & Independent Non-Executive Director | 1.9yrs | AU$41.74k | 0.97% A$ 437.5k | |
| Non-Executive Chair | 2.3yrs | AU$90.00k | 11.09% A$ 5.0m | |
| Independent Non-Executive Director | 1.7yrs | AU$46.33k | no data |
2.1yrs
Average Tenure
Experienced Board: COV's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.